The key differentiator between RTM platforms is whether the patients need to wear sensors and/or wearables or if the technology is so advanced that the technology can track the patients’ movements without wearables simply through a smart device or computer. What is RTM and...
The luminal A subtype is more often low-grade and has a good prognosis; in this case, chemotherapy is not systematic and is discussed according to the response to hormone therapy. The luminal B subtype is more often high-grade, with a poorer response to hormone therapy, and therefore ...
Cell-permeable agonists also work [10]. However, their therapeutic potential is limited, because in vivo their efficacy as pharmacochaperones is compounded by agonist-induced desensitization of the receptor. The pharmacochaperoning action of orthosteric ligands relies—at least in part—on the presence...
Effects of lithium therapy on bone mineral metabolism: A two-year prospective longitudinal study. J. Clin. Endocrinol. Metab. 1998, 83, 3857–3859. [CrossRef] 24. Aslam; Chettle, D.R.; Pejovic-Milic, A.; Waker, A.J. Opportunities to improve the in vivo measurement of manganese in ...
It can be anticipated that big data will have a profound impact, potentially enabling the dissection of differences and oscillations in sleep dynamics and architecture at the individual level ("sleepOMICS"), thus paving the way for a targeted, "one-size-does-not-fit-all" management of sleep ...
gondii-specific activated T-cells than patients who discontinued the maintenance therapy and were relapse-free. This data suggests that the evaluation of T. gondii-specific immune responses by Elispot can improve the estimates of the individual risk of TE and TE relapses. Trypanosoma cruzi is the...
Journal of Fungi Review One Century of Study: What We Learned about Paracoccidioides and How This Pathogen Contributed to Advances in Antifungal Therapy Erika Seki Kioshima 1,*, Patrícia de Souza Bonfim de Mendonça 1, Marcus de Melo Teixeira 2 , Isis Regina Grenier Capoci 1, André Amaral...